Youcare Pharmaceutical Group Co. Ltd. A - Asset Resilience Ratio
Youcare Pharmaceutical Group Co. Ltd. A (688658) has an Asset Resilience Ratio of 10.25% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how financially flexible is Youcare Pharmaceutical Group Co. Ltd. A to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2024–2025)
This chart shows how Youcare Pharmaceutical Group Co. Ltd. A's Asset Resilience Ratio has changed over time. See Youcare Pharmaceutical Group Co. Ltd. A balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Youcare Pharmaceutical Group Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Youcare Pharmaceutical Group Co. Ltd. A (688658) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥531.77 Million | 10.25% |
| Total Liquid Assets | CN¥531.77 Million | 10.25% |
Asset Resilience Insights
- Moderate Liquidity: Youcare Pharmaceutical Group Co. Ltd. A has 10.25% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Youcare Pharmaceutical Group Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Youcare Pharmaceutical Group Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX |
Biotechnology | 10.93% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 0.05% |
|
Hebei Changshan Biochem Pharma
SHE:300255 |
Biotechnology | -0.03% |
|
Neuren Pharmaceuticals Ltd
AU:NEU |
Biotechnology | 90.43% |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076 |
Biotechnology | 2.30% |
|
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871 |
Biotechnology | 6.52% |
|
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880 |
Biotechnology | 5.52% |
Annual Asset Resilience Ratio for Youcare Pharmaceutical Group Co. Ltd. A (2024–2025)
The table below shows the annual Asset Resilience Ratio data for Youcare Pharmaceutical Group Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 7.64% | CN¥397.81 Million ≈ $58.21 Million |
CN¥5.21 Billion ≈ $761.98 Million |
+4.85pp |
| 2024-12-31 | 2.79% | CN¥160.25 Million ≈ $23.45 Million |
CN¥5.74 Billion ≈ $839.67 Million |
-- |
About Youcare Pharmaceutical Group Co. Ltd. A
Youcare Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It offers drugs in various forms, such as injection, lyophilized powder injection, pills, tablets, capsules, ointments, creams, granules, etc. The company provides drugs in various categories, including covering cardio-cerebrovascular, antivirals, central… Read more